NetTargets

BiotechnologySeries ADaejeon, South Koreanet-targets.com

Latest round

Series A

Last raised

Jul 2021

Total raised

$5.3M

Investors

9

About NetTargets

Based in Daejeon, South Korea, and founded in 2019 by Je-Hoon Song, and Jongho Baek (CEO), NetTargets Inc. operates as a biotechnology company that utilizes artificial intelligence to discover new drug candidates. In July 2021, NetTargets Inc. NetTargets Inc. is a developer of a drug development technology system based on systems biology research that is intended to provide an efficient method of drug discovery. The company's system aids in drug discovery by providing interpretable predictions, allowing clinicians to make the best decisions for successful drug development. The company's software consists of a drug database and a mechanism analysis platform that reduce the cost and time of drug development.

Who invested in NetTargets

9 investors across 2 rounds

See all investors in NetTargets

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 2, 2021

    Amount

    $5.3M

    Investors

    Locked

  2. Seed

    Oct 25, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about NetTargets

Who invested in NetTargets?

NetTargets has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has NetTargets raised?

NetTargets has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did NetTargets last raise money?

NetTargets's most recent round on record is a Series A, in Jul 2021.

What does NetTargets do?

Based in Daejeon, South Korea, and founded in 2019 by Je-Hoon Song, and Jongho Baek (CEO), NetTargets Inc.

Where is NetTargets headquartered?

NetTargets is headquartered in Daejeon, South Korea.

Which VCs invest in companies like NetTargets?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NetTargets's stage. Their profiles are linked below.

Raising like NetTargets? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.